Assyro AI

Orange Book product · Brand (NDA)

MEZLIN

MEZLOCILLIN SODIUM MONOHYDRATE

Brand (NDA)NDA 050549DISCN BAYER PHARMS

At a glance

Mar 02, 1988

Approved

Brand (NDA)

Application

Not listed

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Mar 02, 1988

    38 yr 10 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

MEZLOCILLIN SODIUM MONOHYDRATE

Strength

EQ 20GM BASE/VIAL

Dosage form

INJECTABLE

Route

INJECTION

TE code

Not listed

Application

NDA 050549

Product number

005

Marketing status

DISCN

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

This is a brand (NDA) product. Other products sharing this active ingredient are listed below.

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.